ConductScience.org, home
Cell lines
API referenceFor AI assistants

Cell line · CVCL_1511

NCI-H1975

Cancer cell line, Homo sapiens. Lung adenocarcinoma. 190 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. NCI-H1975. Cell lines, record CVCL_1511. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1511

On this page

Cell line

As Cellosaurus gives it.

Name
NCI-H1975
Accession
CVCL_1511
RRID
RRID:CVCL_1511
Synonyms
H1975, H-1975, NCIH1975
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
Age unspecified
Category
Cancer cell line
Diseases
Lung adenocarcinoma (NCIt C3512)
Derived from
Lung (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers190

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

PaperJournalYearHow we knowRetractedSource
Circulating Tumour Cell GALNT13 Expression Is Associated with Prognosis and Treatment Response in Non-Small Cell Lung Cancer.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer.Biomedicines2026Its Methods give the RRID and name the linePubMed
PRAME Augments K63-Linked Ubiquitination and Stabilization of METTL3 to Promote Lung Adenocarcinoma Metastasis.MedComm (2020)2026Its Methods give the RRID and name the linePubMed
Fc-Dependent Targeting of the GAS6-MERTK Axis With Monoclonal and Bispecific Antibodies Overcomes Drug Resistance Across EGFR Mutations in Exons 19, 20, and 21.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Targeting the EpCAM-AXL axis to overcome drug resistance in lung cancer.Mol Oncol2026Its Methods give the RRID and name the linePubMed
NAPRT loss promotes lung tumor initiation and growth through AKT signaling independently of NAD+ biosynthesis.Mol Oncol2026Its Methods give the RRID and name the linePubMed
E3 ubiquitin ligase MAGI3‑mediated TAZ ubiquitination suppresses the non‑small cell lung cancer occurrence and development by targeting the Wnt pathway.Int J Oncol2026Its Methods give the RRID and name the linePubMed
Fast tumor accumulation and payload release of c-Met targeting aptamer-drug conjugate enables robust anti-tumor efficacy.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.Biomolecules2026Its Methods give the RRID and name the linePubMed

1 to 10 of 190

See all 190 papers

Relatives28

RelationCell lineAccessionProblemSource
Derived from itEDITGENE NCI-H1975-CopGFPCVCL_F6B2Cell lines
Derived from itEDITGENE NCI-H1975-FLUCCVCL_F5TECell lines
Derived from itH1975 BIRCVCL_E4DICell lines
Derived from itH1975/Cas9-hygCVCL_C9BLCell lines
Derived from itH1975/OR [China Dongguan]CVCL_B0JTCell lines
Derived from itH1975/OR [China Guangzhou]CVCL_B0JSCell lines
Derived from itH1975/WRCVCL_DG25Cell lines
Derived from itHyCyte NCI-H1975 KO-hARTNCVCL_F1S7Cell lines
Derived from itHyCyte NCI-H1975 KO-hKIF18BCVCL_F1S8Cell lines
Derived from itHyCyte NCI-H1975 KO-hTP53CVCL_F1S9Cell lines

1 to 10 of 28

See all 28 relatives

Cell banks9

Cell bankCatalog numberStatusSource
ATCCCRL-5908ATCC
AddexBioC0016013/4946Cellosaurus
BCRJ0352BCRJ
CLS305067CLS
EDITGENEEDC00249EDITGENE
HysigenTCH-C276Hysigen
ICLCHTL06001ICLC
KCBKCB 2014034YJCellosaurus
UbigeneYC-C106Ubigene

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1511

GET https://conductscience.org/api/cell-lines/v1/CVCL_1511/papers?page=2

API referenceFor AI assistants